We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · September 25, 2022

Busulfan Plus Cyclophosphamide vs Total Body Irradiation Plus Cyclophosphamide for Adults With B-ALL

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial
J. Clin. Oncol 2022 Sep 09;[EPub Ahead of Print], H Zhang, Z Fan, F Huang, L Han, Y Xu, N Xu, L Deng, S Wang, D Lin, X Luo, Q Zhang, X Liu, X Li, X Liang, S Xie, H Qu, S Yu, H Zhou, P Shi, L Xuan, R Lin, H Liu, H Jin, J Sun, Q Liu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading